UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.
Dr Pooni succeeds current chief executive Dr Berwyn Clarke who becomes chairman, while Dr Mike Lewis moves from chairman to non-executive director.
With over 19 years experience in leading life science businesses, Dr Pooni joins Glyconics from Astellas Pharmaceutical Europe where he served as senior director of European commercial operations and effectiveness among other roles.
Dr Clarke said: “Kam is a proven leader, with an impressive combination of vision, passion and experience building and managing pharmaceutical businesses and will play a major role in the development of the business as well as bringing additional experience to the board.
“I look forward to working closely with him at this exciting stage of the company’s development.”